Funding for 12 months for a Fellow to support the running of the clinical trials and to skill up for independent practice as a Movement Disorders Neurologist with expertise in Fragile XTAS, Neurogenetics and the Clinical Genomics Unit. The Fellow will be involved in supporting the Fragile X mutation carrier (FXTAS) Clinic, the Neurogenetics Clinic and the Clinical Genomics Unit.
The Fellow will also gain valuable experience in the use of the MRI-guided focused ultrasound. (MRgFUS) stereotactic brain ablation is a safe and effective treatment for essential tremor, dystonic tremor and Parkinson’s disease tremor. The MRgFUS has marked a new era in incisionless, minimally invasive therapies for movement disorders. Beyond its existing application for tremor suppression, there exists great potential for the development of new targets to treat and improve the lives of patients with movement disorders, such as focal hand dystonia. The St Vincent’s Hospital MRgFUS Unit is an Australian first.
